Thus, using MYCN-amplified neuroblastoma (NB) as a solid tumor model characterized by constitutive transcriptional upregulation16, and genomic instability17,18, but lacking CDK12 mutation19, we demonstrate a mechanistic link between the structural properties of DDR genes and their susceptibility to CDK12 inhibition. The gene discussed is MYCN; the disease is neuroblastoma.